Business Wire09.13.19
Penumbra Inc. announced U.S. commercial availability of the Penumbra System’s most advanced technology, the Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology. Penumbra JET 7 with XTRA FLEX technology is used with the Penumbra ENGINE in the fully integrated Penumbra System, an aspiration-based mechanical thrombectomy system that enables physicians to extract thrombus in acute ischemic stroke patients.
The Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology is the latest advancement in the Penumbra System JET – ENGINE family of products, which was launched last September. As the Penumbra System’s eighth generation reperfusion catheter for proximal large vessel occlusions, the catheter is designed for advanced trackability and navigation, and maintains the large 0.072” lumen. Penumbra JET 7 with XTRA FLEX technology, together with the power of the Penumbra ENGINE, are designed to maximize thrombus removal force.
The Penumbra System is a fully integrated system designed specifically for mechanical thrombectomy by aspiration that first received 510(k) clearance by the U.S. Food and Drug Administration in December 2007. The Penumbra System enables physicians to use aspiration, which acts like a minimally invasive “vacuum” inside the artery to remove stroke-causing blood clots from the brain safely and effectively. It is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusion. The latest generation of the Penumbra System features the Penumbra JET 7 with XTRA FLEX technology and Penumbra JET D Reperfusion Catheters, the 3D Revascularization Device, and Penumbra ENGINE and accessories. The Penumbra System includes the new Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology powered by the Penumbra ENGINE, offering the highest thrombus removal force for revascularization of acute ischemic stroke patients with large vessel occlusions. Thrombus removal force is calculated based on catheter tip size and vacuum level of the aspiration source.
Penumbra Inc., headquartered in Alameda, Calif., is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra, the Penumbra P logo, Penumbra System, Penumbra JET, 3D Revascularization Device and Penumbra ENGINE are trademarks of Penumbra Inc.
The Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology is the latest advancement in the Penumbra System JET – ENGINE family of products, which was launched last September. As the Penumbra System’s eighth generation reperfusion catheter for proximal large vessel occlusions, the catheter is designed for advanced trackability and navigation, and maintains the large 0.072” lumen. Penumbra JET 7 with XTRA FLEX technology, together with the power of the Penumbra ENGINE, are designed to maximize thrombus removal force.
The Penumbra System is a fully integrated system designed specifically for mechanical thrombectomy by aspiration that first received 510(k) clearance by the U.S. Food and Drug Administration in December 2007. The Penumbra System enables physicians to use aspiration, which acts like a minimally invasive “vacuum” inside the artery to remove stroke-causing blood clots from the brain safely and effectively. It is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusion. The latest generation of the Penumbra System features the Penumbra JET 7 with XTRA FLEX technology and Penumbra JET D Reperfusion Catheters, the 3D Revascularization Device, and Penumbra ENGINE and accessories. The Penumbra System includes the new Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology powered by the Penumbra ENGINE, offering the highest thrombus removal force for revascularization of acute ischemic stroke patients with large vessel occlusions. Thrombus removal force is calculated based on catheter tip size and vacuum level of the aspiration source.
Penumbra Inc., headquartered in Alameda, Calif., is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra, the Penumbra P logo, Penumbra System, Penumbra JET, 3D Revascularization Device and Penumbra ENGINE are trademarks of Penumbra Inc.